“5am-ventures” Archives

Entry Author Date Location
Crinetics Pharmaceuticals Lands $40,000,000 Series A Financing Round 11/03/15 San Diego
Crinetics Pharma Raises $40M in Comeback for Ex-Neurocrine Bio Team 11/02/15 San Diego
Arvinas Obtains $41,600,000 Series B Funding 10/21/15 Boston
Portal Instruments Secures $25,000,000 Series B Financing Round 10/20/15 Boston
Audentes Therapeutics Garners $65,000,000 Series C Funding 10/14/15 San Francisco
After Reinvention, Pulmatrix Wraps Up Ruthigen Deal, Heads to Nasdaq 06/16/15 Boston
In Mental Health Therapy, Cautious Steps Toward the Pharmacodigital 03/17/15 National
Any Given Cell: Can Biotech Pioneer Steve Fodor Do it Again? 02/13/15 San Francisco
Cidara’s $42M Series B May Bring Fungal Therapy to Patients 02/11/15 San Diego
MoneyTree Reports $121M in MI Venture Deals Last Quarter 07/22/14 Detroit Ann Arbor
With $32M, Boston Anti-Fungal Startup Morphs Into San Diego’s Cidara 06/30/14 San Diego
San Diego Biotech Raises Over $30M to Fight Deadly Fungal Infections 06/25/14 San Diego
San Diego’s Ambrx Files for IPO to Advance Antibody-Drug Conjugates 05/05/14 San Diego
Lightstone Closes $172M Fund for Early-Stage Biotechs 05/01/14 Boston
Igenica Follows Genentech Into Antibody-Linked Cancer Drugs 04/11/14 San Francisco
Foresite Capital Reloads With New $300M Late-Stage Biotech Fund 04/01/14 San Francisco
East Coast Biotech Roundup: Neurophage, Boston Biotech, Insmed, & More 03/28/14 Boston
San Diego’s RuiYi Raises $15M for Pipeline of Biologic Therapeutics 03/28/14 San Diego
Flexion Prices IPO at $13, Heads to Nasdaq Tomorrow 02/11/14 Boston
Igenica Lands $14,000,000 Series C Financing Round 01/28/14 San Francisco
What Biotech Pros Will Be Chirping About at JP Morgan This Week 01/13/14 National
Flexion Files for IPO, Seeks $86M to Develop Osteoarthritis Drugs 01/08/14 Boston
5AM Ventures, an Early Stage Biotech VC Still Standing, Raises $250M 12/04/13 San Francisco
Atterocor Begins Phase 1 Trial for Adrenal Cancer Drug 11/01/13 Detroit Ann Arbor
Biodesy Garners $15,000,000 Series A Financing Round 10/18/13 San Francisco
Arvinas Obtains $19,250,000 Series A Financing Round 09/27/13 Boston
East Coast Life Sciences Roundup: Syndax, Enteris, Invivo, & More 08/30/13 Boston
Audentes, Loaded With $30M, Pursues Gene Therapy for Rare Diseases 07/26/13 San Francisco
Audentes Therapeutics Obtains $30,000,000 Series A Funding Round 07/19/13 San Francisco
Ceterix Comes Out With Tool to Repair, Not Remove, Knee Cartilage 07/16/13 San Francisco
Page 1 of 4 next page »